Stay updated with breaking news from Cascade Prodrug. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research by Oregon State University has uncovered a potential new therapy for pancreatic cancer, whose survival rate is among the lowest of all malignancies.
The new therapy is led by OSU researchers as well as Eugene based company Cascade Prodrug Inc.
The new therapy is led by OSU researchers as well as Eugene based company Cascade Prodrug Inc.
PORTLAND, Ore. – Research by Oregon State University has uncovered a potential new therapy for pancreatic cancer, whose survival rate is among the lowest of all malignancies. About one person in 64 will be diagnosed with pancreatic cancer, according to the American Cancer Society. The pancreas is an abdominal organ that regulates blood sugar and also helps with digestion.